Translating Pre-Clinical Research to Clinical Patient Care™
- MSACL 2025
- Details
- Description
- Financial Disclosure
- Steering Committee
- Getting There
- Deadlines
- Invited Speakers
- Venue
- Hotel
- Registration
- Short Courses
- Abstracts
- Troubleshooting Cases
- Exhibits
- Industry Workshops
- Guided Tours
- Local Activities
- Places to Eat
- Conference Policies
- Invitation Letter Request
- CME Credits
- Getting Home
- Call for ...
- Abstract Info
- Educational Grants
- Recognition Awards
- Promotional Material
- For Exhibitors
- Details
- Connect
- Events
- Future
- Past
- MSACL 2024
- MSACL 2023
- MSACL 2022
- MSACL 2021 EU
- MSACLx 2020 Saint Malo
- MSACL 2020 US
- MSACL 2019 EU
- MSACL 2019 US
- MSACL 2018 EU
- MSACL 2018 US
- MSACL 2017 EU
- MSACL 2017 US
- MSACL 2016 EU
- MSACL 2016 US
- MSACL 2015 EU
- MSACL 2015 US
- MSACL 2014 EU
- MSACL 2014 US
- MSACL 2013
- MBDxA 2013
- MSACL 2012
- MSACL 2011
- MSACL 2010
- MSACL 2008
- Asilomar 2007
- Related Events
- JMSACL
- CE CME Certs
- Learning Center
- Resources
- About
Learning CenterAccess additional learning opportunities. |
Bench-to-Clinic
Discussion
Understanding the strategic landscape surrounding the implementation of mass spectrometry in
the clinical laboratory: A SWOT analysis
Michael Vogeser, Y. Victoria Zhang. Clinical Mass Spectrometry (2018)
Join the conversation
© 2024 MSACL (a 501c3 Non-Profit California Corporation)